

| Catalog No. | HF589022 |
|---|---|
| Description |
Recombinant Human VIP Protein, N-GST & C-His (HF589022) expressed in E. coli, spanning Tyr29-Pro164. Purity: >90% by SDS-PAGE.
Highlights
|
| Expression system | E. coli |
| Accession | P01282 |
| Protein length | Tyr29-Pro164 |
| Applications | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Species | Homo sapiens (Human) |
| Nature | Recombinant |
| Endotoxin level | Please contact with the lab for this information. |
| Purity | >90% as determined by SDS-PAGE. |
| Predicted molecular weight | 43.49 kDa |
| Form | Lyophilized |
| Storage buffer | Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Reconstitution | Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details. |
| Shipping | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | Intestinal peptide PHM-27, Intestinal peptide PHV-42, PHM-27, PHV-42, Peptide histidine methioninamide 27, Peptide histidine valine 42, VIP, VIP peptides, Vasoactive intestinal peptide, Vasoactive intestinal polypeptide |
| Background | VIP peptides is a ~19 kDa protein. VIP is a neuropeptide involved in a diverse array of physiological processes through activating the PACAP subfamily of class B1 G protein-coupled receptors: VIP receptor 1 (VPR1) and VIP receptor 2 (VPR2). Abundantly expressed throughout the CNS and peripheral nervous systems where they primarily exert neuroprotective and immune modulatory roles. Also causes vasodilation, lowers arterial blood pressure, stimulates myocardial contractility, increases glycogenolysis and relaxes the smooth muscle of trachea, stomach and gall bladder. 1. Kitamura, K. et al. (1992) Biochemical and biophysical research communications 185, 134-41. PMID: 1318039 2. Piper, SJ. et al. (2022) Nature communications 13, 7013. PMID: 36385145 3. Wei, Y. et al. (1996) Journal of neuroendocrinology 8, 811-7. PMID: 8933357 4. Brenneman, DE. et al. (1986) Proceedings of the National Academy of Sciences of the United States of America 83, 1159-62. PMID: 3456568 5. Ma, JN. et al. (2004) Biochemical pharmacology 67, 1279-84. PMID: 15013843 |
| Note | For research use only |
Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com
+86-27-87433958
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский